Rheumatoid Arthritis – Epidemiology – Epidemiology Data Slicer

launch Related Market Assessment Reports

• Rheumatoid Arthritis – Landscape & Forecast – Disease Landscape & Forecast

  November 2023

  Although tumor necrosis factor-alpha (TNF-α) inhibitors remain the most widely prescribed biologics for rheumatoid arthritis (RA) patients refractory to conventional DMARD treatment (the first-…

• Rheumatoid Arthritis – Geographic Focus – China – Rheumatoid Arthritis – China In-Depth (China)

  October 2023

  Rheumatoid arthritis (RA) is a chronic and progressive autoimmune disease that primarily affects the joints. China has the highest number of RA patients in the world, and disease management is…

• Amyotrophic Lateral Sclerosis – Landscape & Forecast – Disease Landscape & Forecast

  September 2023

  Amyotrophic lateral sclerosis (ALS) is a progressively debilitating disorder of the central nervous system characterized by motor neuron degeneration. ALS causes progressive weakness and atrophy of…

• Asthma – Access & Reimbursement – Detailed, Expanded Analysis (US)

  August 2023

• Celiac Disease – Epidemiology – Mature Markets

  August 2023

  Clarivate Epidemiology’s coverage of celiac disease comprises epidemiological estimates of key patient populations in the major mature pharmaceutical markets (the United States, France, Germany,…